Gandeeva Therapeutics Funding: $40M Raised, Series A (2021)
Gandeeva Therapeutics is based in Burnaby, Canada. It has raised $40M in total funding. Latest round: Series A.
Gandeeva Therapeutics funding overview
Gandeeva Therapeutics is based in Burnaby, Canada. Gandeeva Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Gandeeva Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Lux Capital, Leaps by Bayer, Obvious Ventures, Amgen Ventures, Air Street Capital. 5 distinct backers are named across the disclosed rounds.
Gandeeva Therapeutics at a glance
Total raised
$40M
Latest round
Series A
Latest round date
May 2021
Headquarters
Burnaby, Canada
Notable investors
Lux Capital, Leaps by Bayer, Obvious Ventures, Amgen Ventures, Air Street Capital
Frequently asked about Gandeeva Therapeutics funding
How much has Gandeeva Therapeutics raised?
Gandeeva Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Gandeeva Therapeutics?
Lux Capital, Leaps by Bayer, Obvious Ventures, Amgen Ventures, Air Street Capital are named among the investors backing Gandeeva Therapeutics.
What was the latest Gandeeva Therapeutics funding round?
The most recent disclosed round is a Series A, announced in May 2021.
Where is Gandeeva Therapeutics based?
Gandeeva Therapeutics is based in Burnaby, Canada.
When did Gandeeva Therapeutics last raise?
The last disclosed Gandeeva Therapeutics round closed in May 2021 at Series A.
Totals shown for Gandeeva Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Burnaby and the investors behind them below.
